Navigation Links
PDS Biotechnology Corporation Progresses Development of Nanotechnology Cancer Therapies
Date:11/6/2008

CINCINNATI, Nov. 6 /PRNewswire/ -- PDS Biotechnology Corporation today announced that the company has been selected as a collaborator of the US National Cancer Institute's Nanotechnology Characterization Lab (NCL) to complete preclinical development of Versamune(TM)-HPV prior to filing of the Investigational New Drug Application. The NCL will perform selected physical, chemical and biological studies on behalf of the company at its facilities at the National Cancer Institute (NCI) in Frederick, Maryland. Dr. Frank Bedu-Addo, President of the Corporation stated that, "PDS Biotechnology Corporation's partnership with the NCL provides significant value to the company. The invaluable expertise of the NCL's scientists will provide the company with additional expert resources and technologies, and will facilitate rapid development of the product."

Versamune(TM)-HPV is an immunotherapy drug which has demonstrated significant promise in curing HPV infection and HPV-related cancer in preclinical animal and human model studies. Cancers caused by infection with the human papilloma virus (HPV) include cervical, head and neck and anal cancers. No cures exist for these cancers. Based on promising in vivo and in vitro efficacy data, PDS Biotechnology Corporation was awarded in August 2008, a phase I SBIR grant by the US National Institutes of Health/National Cancer Institute to develop Versamune(TM)-Melanoma to treat melanoma, which is the most aggressive form of skin cancer.

PDS Biotechnology Corporation's Versamune(TM) nanotechnology facilitates the uptake of disease-associated protein and peptide antigens by the antigen- presenting cells of the immune system and simultaneously acts a strong immune system activator (adjuvant) without the inflammatory side effects induced by current adjuvants. The result is simple, safe and cost effective nanotechnology-based drugs and vaccines that induce effective eradication of the specific cells infected with, or expressi
'/>"/>

SOURCE PDS Biotechnology Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
2. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
3. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
4. Dr. Ari Kiev to be Featured Speaker at Biotechnology Conference Wall Street Unplugged: The Trout Group Investor Seminar in New York July 30
5. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
6. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
7. Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D
8. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
9. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
10. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
11. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., WESTON, Mass., Nov. 9 Groundbrea...ioid Management, for the first time explore, in ...challenges for health care providers and its poten...nt articles, University of Washington authors, Sun...s Medical Scientist Training Program and who condu...
(Date:11/9/2009)..., SUNNYVALE, Calif., Nov. 9 Asthma...ies investigating the effectiveness and safety of ...; System, and how this new procedure will impact a... the 2009 Annual Meeting of the American College o... Beach, Fla. ,, The poster, titled "Where Could...
(Date:11/9/2009)..., INDIANAPOLIS, Nov. 9 AMD LASERS ...expert, Dr. James Jesse, has accepted the position...will be responsible for overseeing research and de...s, standards and compliance for continuing educati...views and trade publications, and lecturing and se...
Breaking Medicine Technology:Medicinal Use of Marijuana: Past, Present and Future...A Fresh Look by Experts in the Field 2Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 2Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 3AMD LASERS Names Dr. James Jesse as Medical Director 2New Classification Proposed for Stomach Cancers 58771 1New Classification Proposed for Stomach Cancers 58771 2Cyberonics Announces Epilepsy Technology Collaborations 58767 1Cyberonics Announces Epilepsy Technology Collaborations 58767 2Cyberonics Announces Epilepsy Technology Collaborations 58767 3Cyberonics Announces Epilepsy Technology Collaborations 58767 4Yongye International Announces 2010 2012 Strategic Plan 14335 1Yongye International Announces 2010 2012 Strategic Plan 14335 2Yongye International Announces 2010 2012 Strategic Plan 14335 3Yongye International Announces 2010 2012 Strategic Plan 14335 4Yongye International Announces 2010 2012 Strategic Plan 14335 5
...N.J., Oct. 17 Ten abstracts providing new,analyse...udies for,MIRCERA(R) will be presented at the upco...f Nephrology (ASN) in San Francisco on November 2 ...es from maintenance studies,including MAXIMA, PROT...uding ARCTOS and AMICUS. Please note all informat...
...dress corrected, WASHINGTON, Oct. 16 The followi... WHAT: Press briefing conference call to discuss ...cs (AAP) and Trust for America,s Health (TFAH),"Pa...report identifies gaps,in U.S. preparedness in tre...ndemic flu outbreak and provides recommendations f...
Other Medicine Technology:New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting 2New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting 3New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting 4
(Date:11/9/2009)... New study highlights positive inf... Rosemont, IL (Vocus) Novemb... bone health decreases. Recent research has highli...ements to help prevent these issues. However, a ne...f Sports Health: A Multidisciplinary Approach re...
(Date:11/9/2009)...CAGO, Nov. 9 Highlighting a commit...s with advanced entertainment and digital display ...ts latest Long-Term Care and Hospital Grade LCD HD...ices for the Aging 2009 annual meeting and exposit... the new line of "HealthView(TM)" Long-Term Care L...
(Date:11/9/2009)... YORK, Nov. 9 /PRNewswire/ -- Phoenix House ,...abuse treatment and prevention program, announced ...ionally and internationally recognized leader in s...inical Officer, effective January 1, 2010. ,,...tance abuse treatment research and her work has re...
(Date:11/9/2009)... Parents Support Experimental Procedure for Pretee...SNewswire/ -- For parents of children with cancer,... have steadily improved for decades. Among the bad...se infertility. ,, Boys diagnosed with cancer...unity to preserve their fertility: before undergoi...
(Date:11/9/2009)...e Children,s Research Hospital and the University ...collaboration to provide proton therapy for St. Ju... of the first clinical study to evaluate the use o...n younger than 3 years old. , Under the clinic...ve proton therapy at the UF Proton Therapy Institu...
Breaking Medicine News(10 mins):Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 2Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 3Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 4Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 5Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 4Health News:St. Jude and UF Proton Therapy Institute to begin proton therapy clinical trial 2
...dates, federal and state politicians, the health c...ver the next year to gauge the success --,or failu...lly in states,like Massachusetts., In place since...ner more attention this spring as penalties for co...
... and Drug Administration (FDA) are discussing how ...ossible to collect better data about experimental ...rements. , Researchers from the National Institut...re an audience of their peers on November 28-29, 2...
...al,Inc. (Nasdaq: BFRM ) today announced its finan...07, which is the Company,s second quarter of fisca...quarter ended December 31,2007 as compared to $11....1, 2007 as compared to $2.7 million for the quarte...
...meriHealth Mercy,s product offerings ...Jan. 31 The AmeriHealth Mercy Family of,Companies...ced today that,it has acquired Community Behaviora... a wholly owned subsidiary of,AmeriHealth Mercy, s...
...Nursing Home Care to Face,Severe Resistance, JOPL...rticle today reporting the Bush Administration pla...home care in his FY 2009 budget to,be unveiled Mon... at the state and national levels in opposing,cong...
...,issued the following statement today following ne... Medicare and Medicaid when he unveils his fiscal,...ng to once again slash health care coverage,for se...ontinue to rise and families are feeling economica...
Other Medicine News:Health News:Survey: Massachusetts Employers, Employees Paying Most for Health Care Plans 2Health News:Survey: Massachusetts Employers, Employees Paying Most for Health Care Plans 3Health News:Researchers query FDA about updating requirements for drug approval 2Health News:BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008 2Health News:BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008 3Health News:BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008 4Health News:BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008 5Health News:BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008 6Health News:BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008 7Health News:AmeriHealth Mercy Family of Companies Acquires Community Behavioral HealthCare Network of Pennsylvania 2Health News:Coalition to Protect Senior Care Gearing Up to Fight Bush Administration Medicare Cuts 2
MultiWash Advantage
Synchron
...y method for HbA1c provides outstanding accuracy a...ment with the HPLC method(1) , Near-patient resu...ults are reliable(2) , National Glycohemoglobin ...s recommended by the ADA** , , , Microalbum...
Blood Coagulation Analyzer CG Series
Medicine Products: